Table 1.
Oligomer | Sequence | #MP units |
---|---|---|
PNA1 | H-GCATGTTTGA-NH2 | 0 |
PNA2 | H-GCATGTTTGA-NH2 | 1 |
PNA3 | H-GCATGTTTGA-NH2 | 3 |
PNA4 | H-GCATGTTTGA-NH2 | 5 |
PNA5 | H-GCATGTTTGA-NH2 | 10 |
| ||
PNA6 | H-ACGGGTAGAATAACAT-NH2 | 0 |
PNA7 | H-ACGGGTAGAATAACAT-NH2 | 1 |
PNA8 | H-ACGGGTAGAATAACAT-NH2 | 3 |
PNA9 | H-ACGGGTAGAATAACAT-NH2 | 5 |
PNA10 | H-ACGGGTAGAATAACAT-NH2 | 8 |
| ||
PNA1X | H-LOrn(X)-LLys-GCATGTTTGA-NH2 | 0 |
PNA1Y | H-LLys-GCATGTTTGA-LOrn(Y)-NH2 | 0 |
PNA4X | H-LOrn(X)-LLys-GCATGTTTGA-NH2 | 5 |
PNA4Y | H-LLys-GCATGTTTGA-LOrn(Y)-NH2 | 5 |
Underlined letter indicates R-MP-γ-backbone modification. X = fluorescein (FITC), Y = tetramethylrhodamine (TAMRA).